It was reported that the procedure was to treat a heavily calcified, moderately tortuous, 90% stenosed lesion in the distal right coronary artery (drca).A 2x12mm traveler rx balloon dilatation catheter (bdc) was advanced to the target lesion with resistance from the anatomy and inflated to 6 atmospheres (atm) when a leak of contrast was observed coming from the balloon.The bdc was removed with resistance met from the anatomy and another same size traveler rx bdc was used to successfully complete the procedure.There was no adverse patient effect and no clinically significant delay in the procedure.No additional information was provided.
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history of the reported lot did not indicate a lot specific quality issue.The investigation determined the reported complaint appears to be related to operational context.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.The traveler rx is currently not commercially available in the us; however, it is similar to a device sold in the us.
|